Importance of performance status prior to starting regorafenib at Annual Meeting GI 2016

Importance of performance status prior to starting regorafenib at Annual Meeting GI 2016

464 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Alan P. Venook, MD of University of California San Francisco discusses the importance of performance status prior to starting regorafenib at ASCO GI 2016
Up Next Autoplay
>